Business Context and Reporting Period
This Form 8-K filing by Willis Group Holdings Public Limited Company (Willis) reports on an extraordinary general meeting (EGM) of shareholders held on November 18, 2015. The meeting concerned the proposed merger between Willis and Towers Watson & Co., as outlined in an Agreement and Plan of Merger dated June 29, 2015.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Voting Results
The primary material event was the shareholder vote to adjourn the EGM to allow additional time for consideration of the merger proposals. The voting results were as follows:
- Total Votes Cast: 163,771,880
- Votes For Adjournment: 153,095,180
- Votes Against Adjournment: 8,412,689
- Abstentions: 2,264,011
The EGM was reconvened on November 20, 2015, at 9:30 a.m. Eastern Time at Willis's offices in New York, NY.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statements regarding the anticipated benefits of the business combination, including future financial and operating results. Management highlighted significant risks and uncertainties that could cause actual results to differ from expectations, including:
- Failure to obtain governmental approvals.
- Failure of shareholders to approve the transaction.
- Risks related to business integration and realization of cost savings/synergies.
- Impact on relationships with employees, suppliers, customers, and competitors.
- Changes in economic, business, and political conditions.
Investors are urged to read the joint proxy statement/prospectus filed on Form S-4 for detailed risk factors.
Key Facts for Investor Verification
- Shareholders approved an adjournment of the merger vote to November 20, 2015.
- The merger transaction between Willis and Towers Watson remains pending shareholder approval.
- Over 93% of votes cast supported the adjournment proposal.
- Definitive financial terms and detailed risk factors are contained in the Form S-4 joint proxy statement/prospectus, not this 8-K.